Showing results (291-300 of 322) with videos related to

Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapyS N Bock, R E Lee, B Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim reportJ C Yang, S L Topalian, D Parkinson, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapyB A Pockaj, J C Yang, M T Lotze, et al.
Journal of the National Cancer Institute|August 3, 1994
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2S A Rosenberg, J R Yannelli, J C Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinomaA S Guleria, J C Yang, S L Topalian, et al.
Physical Review Letters|March 10, 2012
Magnetotransport at domain walls in BiFeO3Q He, C-H Yeh, J-C Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremityJ C Yang, A E Chang, A R Baker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanomaM E Dudley, J Wunderlich, M I Nishimura, et al.
Pageof 33